Back to results
US 8,278,300 B2Granted
Use for PDE5 inhibitors
AssigneeNYCOMED GmbH
InventorsTorsten Dunkern, Christian Schudt, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Manfred Kaps, Bernhard Rosengarten
Life of this patent
Estimating the term…
Abstract
The present invention is concerned with the use of PDE5 inhibitors in medicine.
Claims2
A method of treatment of sepsis associated encephalopathy in a patient afflicted with such disease comprising the step of administering a pharmacologically tolerable and therapeutically effective amount of a PDE5 inhibitor to the patient, wherein the PDE5 inhibitor is selected from the group consisting of vardenafil, tadalafil, a pharmaceutically acceptable salt thereof and a hydrate of the pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.